Our Blog

Saphetor SA and 4bases announce partnership

Saphetor SA and 4bases announce partnership

Saphetor SA and 4bases announce partnership to accelerate data interpretation for targeted NGS panels Lausanne, December 3st, 2019. Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions, announced today a...

read more
A new step into precision medicine

A new step into precision medicine

Since the end of May 2019, around 40% of patients with HR+/HER2- breast cancer can count on a new drug developed by Novartis and approved by the FDA. This new development is another important step into the field of precision medicine. Piqray® is indeed specific to...

read more
4bases launches a new website

4bases launches a new website

After the renewal of our ISO13485:2016 certification in May, the entry of new products in our pipeline and the opening of new markets, the Swiss supplier of CE IVD certified genetic diagnostic tests 4bases launches today its new website. Concise but comprehensive, the...

read more